Lifegenix’s Growth is the Result of Business Idea that Benefits All

Baddi, Himachal Pradesh Jul 19, 2022 (Issuewire.com) – One of the leading pharmaceutical companies in India, Lifegenix – a successful venture by Shri Yogendra Chopra, envisions creating a prosperous future for upcoming generations by supporting their entrepreneurial dreams. Lifegenix supports over 500 associates across the Indian market to establish and grow their businesses. Lifegnix is a Division of Lifecare Neuro. The brand is engaged in the marketing and sales of practically all-essential medications ranging from Anti-Convulsants, Anti Asthmatics, Anti Migraine, Anti-Depressants, Antidiabetics, Anti Parkinsonian, Anti-Psychotics, Anxiolytics, to NSAIDs, Vitamins & Minerals, Anti Alcoholism, and many more.

Numerous Indian pharmaceutical titans have demonstrated their fortitude in the global pharma business, and many more upcoming names have showcased potential growth to become future pharmaceutical leaders.

Lifegenix has acquired a strong reputation in the Indian pharma industry by supporting small investors through its PCD Pharma Franchise business model, which allows talented associates to start successful businesses and make their indispensable positions in the competitive pharma sector.

With low capital needs and strong profit margins, Lifegenix has been able to quickly expand its position across a large portion of the country by giving monopoly rights to its franchise partners, a lucrative option for young entrepreneurs. The company has assisted several associates in setting up and expanding their businesses pan India, which implies that the new business owners have set up their operations and received ongoing support for their stable growth.

The Pharmaceutical Industry has several peculiar traits, both in terms of its organizational structure and the nature of its commercial operations, that are seldom understood outside the industry yet have a significant impact on bringing new and innovative medicines to patients.

The ten factors driving market growth in the pharmaceutical sector are – an aging population, over-the-counter (OTC) growth, chronic illnesses, shifting drug status, branded drugs, innovations in medical treatment, reforms in healthcare, and the concurrence of healthcare and technology, and competitive medicine prices.

According to Lifegenix, “Sustainability is the cornerstone of growth and innovation.”

The company works to uphold ethical standards and practices as its guiding principles and strives to continuously improve to the highest quality standards that are consistent for both domestic and international markets. Lifegenix implements its mission of providing the best quality by engaging in high-impact philanthropy, promoting diversity, fostering relationships within the healthcare industry, and upholding the highest business responsibility norms.

Today, Lifegenix is one of the most promising pharma companies for franchise partnering and acquiring quality-assured pharmaceuticals.